Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
5.5%
% of HART's 83 holdings also in XPH
10.0%
% of XPH's 40 holdings also in HART
Overlap by Weight
Sector Drift (HART minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 6.1% | 4.8% | 4.8% |
|
JOHNSON & JOHNSON | 5.0% | 4.5% | 4.5% |
|
PFIZER INC | 4.1% | 4.6% | 4.1% |
|
BRISTOL-MYERS SQUIBB CO | 2.6% | 4.4% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to XPH
 |
NOVO NORDISK A/S-B | 5.5% |
|
ABBOTT LABORATORIES | 5.4% |
 |
NOVARTIS AG | 4.9% |
|
ALPHABET INC. CLASS A | 4.7% |
 |
ASTRAZENECA PLC | 4.6% |
|
APPLE INC | 4.4% |
|
NIKE INC -CL B | 4.4% |
|
UNITEDHEALTH GROUP INC | 4.2% |
|
ELEVANCE HEALTH INC | 2.9% |
 |
MEDTRONIC PLC | 2.8% |
HART Underweight Relative to XPH
|
MERCK & CO. INC. | -4.8% |
|
PERRIGO CO | -4.8% |
|
INTRA-CELLULAR THERAPIES INC | -4.7% |
|
CATALENT INC | -4.7% |
|
JAZZ PHARMACEUTICALS PLC | -4.6% |
|
AXSOME THERAPEUTICS, INC. | -4.6% |
|
ORGANON & CO. | -4.5% |
|
VIATRIS, INC. | -4.5% |
|
ROYALTY PHARMA PLC CLASS A | -4.5% |
|
ELANCO ANIMAL HEALTH, INC. | -4.4% |